189 related articles for article (PubMed ID: 29879269)
1. The Value of Neoadjuvant Chemotherapy in Localized High-Risk Soft-Tissue Sarcoma of the Extremities and Trunk.
Gronchi A; Jones RL
JAMA Oncol; 2018 Sep; 4(9):1167-1168. PubMed ID: 29879269
[No Abstract] [Full Text] [Related]
2. What is the standard indication of adjuvant or neoadjuvant chemotherapy in localized soft-tissue sarcoma?
Hindi N; Martin-Broto J
Curr Opin Oncol; 2021 Jul; 33(4):329-335. PubMed ID: 33973551
[TBL] [Abstract][Full Text] [Related]
3. Low Levels of Evidence for Neoadjuvant Chemotherapy to Treat Soft-Tissue Sarcoma.
George S; Wagner AJ
JAMA Oncol; 2018 Sep; 4(9):1169-1170. PubMed ID: 29879275
[No Abstract] [Full Text] [Related]
4. [Role of neoadjuvant chemotherapy in intermediate/high-grade soft-tissue sarcomas in the adult].
Mori S; Apice G; Ottaiano A; De Chiara A; Germano A; Botti G; De Rosa V; Ravo V; Morrica B; Mozzillo N
Tumori; 2003; 89(4 Suppl):267-8. PubMed ID: 12903615
[No Abstract] [Full Text] [Related]
5. Preoperative chemotherapy and split-course radiation therapy for patients with localized soft tissue sarcomas: home run, base hit, or strike out?
Pisters PW
J Clin Oncol; 2006 Feb; 24(4):549-51. PubMed ID: 16446327
[No Abstract] [Full Text] [Related]
6. Combination of Cisplatin, Ifosfamide, and Adriamycin as Neoadjuvant Chemotherapy for Extremity Soft Tissue Sarcoma: A Report of Twenty-Eight Patients.
Wang B; Yu X; Xu S; Xu M
Medicine (Baltimore); 2016 Jan; 95(4):e2611. PubMed ID: 26825914
[TBL] [Abstract][Full Text] [Related]
7. Has "MAID" made it in the management of high-risk soft-tissue sarcoma?
O'Sullivan B; Bell RS
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):915-6. PubMed ID: 12829123
[No Abstract] [Full Text] [Related]
8. Adjuvant and neoadjuvant chemotherapy for soft tissue sarcomas: JCOG Bone and Soft Tissue Tumor Study Group.
Tanaka K; Ozaki T
Jpn J Clin Oncol; 2021 Feb; 51(2):180-184. PubMed ID: 33313851
[TBL] [Abstract][Full Text] [Related]
9. [Responses of 109 adult soft tissue sarcoma patients to chemotherapy].
Qiu MZ; Xu F; Wang SS; Luo HY; Wang F; Li FH; Sun XF; Xu GC; Lin TY; Huang HQ; Jiang WQ; Guan ZZ; Xu RH
Ai Zheng; 2007 Dec; 26(12):1344-9. PubMed ID: 18076798
[TBL] [Abstract][Full Text] [Related]
10. Should patients with high-risk soft tissue sarcoma receive adjuvant chemotherapy?
Schuetze SM; Patel S
Oncologist; 2009 Oct; 14(10):1003-12. PubMed ID: 19808770
[TBL] [Abstract][Full Text] [Related]
11. The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised trial.
Pasquali S; Pizzamiglio S; Touati N; Litiere S; Marreaud S; Kasper B; Gelderblom H; Stacchiotti S; Judson I; Dei Tos AP; Verderio P; Casali PG; Woll PJ; Gronchi A;
Eur J Cancer; 2019 Mar; 109():51-60. PubMed ID: 30690293
[TBL] [Abstract][Full Text] [Related]
12. [Adjuvant chemotherapy of soft tissue sarcoma].
Lévy E; Thirion P; Piedbois P
Cancer Radiother; 1997; 1(5):462-6. PubMed ID: 9587378
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant and adjuvant therapy for extremity soft tissue sarcomas.
Scurr M; Judson I
Hematol Oncol Clin North Am; 2005 Jun; 19(3):489-500, vi. PubMed ID: 15939193
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant chemotherapy for soft tissue sarcomas.
Ravi V; Patel S
Surg Oncol Clin N Am; 2012 Apr; 21(2):243-53. PubMed ID: 22365517
[TBL] [Abstract][Full Text] [Related]
15. Feasibility of Preoperative Chemotherapy With or Without Radiation Therapy in Localized Soft Tissue Sarcomas of Limbs and Superficial Trunk in the Italian Sarcoma Group/Grupo Español de Investigación en Sarcomas Randomized Clinical Trial: Three Versus Five Cycles of Full-Dose Epirubicin Plus Ifosfamide.
Palassini E; Ferrari S; Verderio P; De Paoli A; Martin Broto J; Quagliuolo V; Comandone A; Sangalli C; Palmerini E; Lopez-Pousa A; De Sanctis R; Bottelli S; Libertini M; Picci P; Casali PG; Gronchi A
J Clin Oncol; 2015 Nov; 33(31):3628-34. PubMed ID: 26351345
[TBL] [Abstract][Full Text] [Related]
16. Treatment of soft-tissue sarcomas: high-dose ifosfamide or combination of ifosfamide and etoposide?
Yalçin S
Ann Oncol; 1999 Jan; 10(1):123-4. PubMed ID: 10076733
[No Abstract] [Full Text] [Related]
17. Ifosfamide in soft tissue sarcoma.
Zaidi SH; Iqbal Z; Mallick JA
J Pak Med Assoc; 1990 Sep; 40(9):222-4. PubMed ID: 2123272
[No Abstract] [Full Text] [Related]
18. Limb salvage by neoadjuvant isolated perfusion with TNFalpha and melphalan for non-resectable soft tissue sarcoma of the extremities.
Lejeune FJ; Pujol N; Liénard D; Mosimann F; Raffoul W; Genton A; Guillou L; Landry M; Chassot PG; Chiolero R; Bischof-Delaloye A; Leyvraz S; Mirimanoff RO; Bejkos D; Leyvraz PF
Eur J Surg Oncol; 2000 Nov; 26(7):669-78. PubMed ID: 11078614
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy, irradiation, and surgery for function-preserving therapy of primary extremity soft tissue sarcomas: initial treatment with ifosfamide, mitomycin, doxorubicin, and cisplatin plus granulocyte macrophage-colony-stimulating factor.
Edmonson JH; Petersen IA; Shives TC; Mahoney MR; Rock MG; Haddock MG; Sim FH; Maples WJ; O'Connor MI; Gunderson LL; Foo ML; Pritchard DJ; Buckner JC; Stafford SL
Cancer; 2002 Feb; 94(3):786-92. PubMed ID: 11857314
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas.
DeLaney TF; Spiro IJ; Suit HD; Gebhardt MC; Hornicek FJ; Mankin HJ; Rosenberg AL; Rosenthal DI; Miryousefi F; Ancukiewicz M; Harmon DC
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):1117-27. PubMed ID: 12829150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]